EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Threshold tracking transcranial magnetic stimulation and neurofilament light chain as diagnostic aids in ALS

Anna B Jacobsen iD, Hugh Bostock, James Howells, Bülent Cengiz, Gintaute Samusyte, Martin Koltzenburg iD, Hossein Pia, Anders Fuglsang-Frederiksen, Jakob Blicher, Izabella Obál, Henning Andersen, Hatice Tankisi iD

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Anna B Jacobsen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus N, 8200, Denmark. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Neurofilament Proteins, Transcranial Magnetic Stimulation, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sundhedsvidenskabelige Fakultet, Aarhus Universitet, Lundbeck Foundation, William Demant Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

There is a need for sensitive biomarkers in amyotrophic lateral sclerosis (ALS), to enable earlier diagnosis and to help assess potential treatments. The main objective of this study was to compare two potential biomarkers, threshold‐tracking short‐interval cortical inhibition (T‐SICI), which has shown promise as a diagnostic aid, and neurofilament light chains (NfL).

Methods

Ninety‐seven patients with ALS (mean age 67.1 ± 11.5 years) and 53 ALS mimics (aged 62.4 ± 12.9) were included. Mean disease duration was 14 months ±14.1. Patients were evaluated with revised ALS functional rating score (ALSFRS‐R), Penn upper motor neuron score (UMNS), muscle strength using the Medical Research Council (MRC) score and examined with T‐SICI, quantitative electromyography (EMG), and NfL measured in spinal fluid.

Results

NfL increased with increasing UMNS ( rho = 0.45, p = 8.2 × 10 −6 ) whereas T‐SICI at 2.5 ms paradoxically increased toward normal values ( rho = 0.53, p = 1.9 × 10 −7 ). However, these two measures were uncorrelated. Discrimination between ALS patients and mimics was best for NfL (area under ROC curve 0.842, sensitivity 84.9%, specificity 83.5%), compared with T‐SICI (0.675, 39.6%, 91.8%). For the patients with no UMN signs, NfL also discriminated best (0.884, 89.3%, 82.6%), compared with T‐SICI (0.811, 71.4%, 82.6%). However, when combining NfL and T‐SICI, higher AUCs of 0.854 and 0.922 and specificities of 93.8 and 100 were found when considering all patients and patients with no UMN signs, respectively.

Interpretation

Both T‐SICI and NfL correlated with UMN involvement and combined, they provided a strong discrimination between ALS patients and ALS mimics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisNeurofilament ProteinsTranscranial Magnetic StimulationBiomarkersHumansMiddle AgedMaleFemaleAgedElectromyographyEvoked Potentials, Motor

Substanzen

Neurofilament Proteinsneurofilament protein LBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus N, 8200, Denmark.
  • UCL Queen Square, Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
  • Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia.
  • Department of Neurology, Gazi University Faculty of Medicine, Beşevler, 06570, Ankara, Turkey.
  • Department of Neurology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, 44307, Lithuania.
  • Department of Neurology, Lithuanian University of Health Sciences Hospital Kauno Klinikos, Kaunas, 50161, Lithuania.

ORCID-Profile: Anna B Jacobsen, Martin Koltzenburg, Hatice Tankisi

Förderung

  • Sundhedsvidenskabelige Fakultet, Aarhus Universitet
  • Lundbeck Foundation
  • William Demant Fonden
  • Familien Hede Nielsens Fond
  • Aage og Johanne Louis-Hansens Fond

Zitieren

APA

Jacobsen, A. B., Bostock, H., Howells, J., Cengiz, B., Samusyte, G., Koltzenburg, M., Pia, H., Fuglsang-Frederiksen, A., Blicher, J., Obál, I., Andersen, H., & Tankisi, H. (2024). Threshold tracking transcranial magnetic stimulation and neurofilament light chain as diagnostic aids in ALS. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52095

Vancouver

Jacobsen AB, Bostock H, Howells J, Cengiz B, Samusyte G, Koltzenburg M, et al. Threshold tracking transcranial magnetic stimulation and neurofilament light chain as diagnostic aids in ALS. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52095

BibTeX
@article{Jacobsen2024,
  author = {Jacobsen, Anna B and Bostock, Hugh and Howells, James and Cengiz, Bülent and Samusyte, Gintaute and Koltzenburg, Martin and Pia, Hossein and Fuglsang-Frederiksen, Anders and Blicher, Jakob and Obál, Izabella and Andersen, Henning and Tankisi, Hatice},
  title = {Threshold tracking transcranial magnetic stimulation and neurofilament light chain as diagnostic aids in ALS},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52095}
}
Kostenlos starten →